News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
960 Results
Type
Article (57)
Press Release (903)
Section
Business (269)
Deals (81)
Drug Development (128)
FDA (32)
Job Trends (13)
News (502)
Policy (31)
Tag
Alliances (50)
Approvals (31)
Artificial intelligence (1)
Bankruptcy (2)
Best Places to Work (11)
Bladder cancer (11)
Cancer (33)
Clinical research (132)
Collaboration (3)
Compensation (3)
C-suite (1)
Data (18)
Diagnostics (6)
Earnings (131)
Events (175)
Executive appointments (1)
FDA (42)
Government (3)
Guidances (1)
Healthcare (16)
Immunology and inflammation (1)
Indications (2)
Infectious disease (3)
IPO (50)
Job creations (2)
Legal (1)
Lung cancer (1)
Medical device (8)
Medtech (8)
Mergers & acquisitions (31)
NextGen: Class of 2025 (7)
Non-profit (2)
Patents (1)
People (88)
Phase I (14)
Phase II (44)
Phase III (72)
Pipeline (2)
Policy (1)
Postmarket research (10)
Preclinical (6)
Prostate cancer (10)
Radiopharmaceuticals (1)
Rare diseases (1)
Regulatory (38)
RSV (2)
Startups (4)
Vaccines (2)
Date
Last 30 days (2)
Last 365 days (78)
2025 (58)
2024 (70)
2023 (58)
2022 (69)
2021 (76)
2020 (110)
2019 (81)
2018 (54)
2017 (42)
2016 (26)
2015 (56)
2014 (54)
2013 (23)
2012 (34)
2011 (30)
2010 (44)
Location
Asia (51)
Australia (6)
California (6)
Europe (130)
Florida (3)
Japan (2)
Massachusetts (4)
New Jersey (52)
New York (3)
Northern California (4)
Ohio (4)
Pennsylvania (3)
Southern California (1)
United States (78)
Utah (3)
960 Results for "urogen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an approval in bladder cancer, and more key regulatory nods from the past month.
June 30, 2025
·
9 min read
·
Tristan Manalac
Press Releases
UroGen Pharma to Present at Upcoming September 2025 Investor Conferences
August 22, 2025
·
1 min read
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 8, 2025
September 9, 2025
·
2 min read
Bladder cancer
UroGen’s Bladder Cancer Drug Wins FDA Approval Over Adcomm’s Objections
The FDA’s Oncologic Drugs Advisory Committee narrowly voted against the approval of Zusduri, citing the lack of a completely randomized study to back up the application.
June 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results
August 8, 2025
·
19 min read
Press Releases
UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025
July 30, 2025
·
1 min read
Press Releases
U.S. FDA Approves UroGen’s ZUSDURI™ (mitomycin) for Intravesical Solution as the First and Only Medication for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
June 13, 2025
·
11 min read
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025
June 9, 2025
·
2 min read
Press Releases
UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update
May 12, 2025
·
19 min read
Press Releases
UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology
July 29, 2025
·
10 min read
1 of 96
Next
